Insider Trading activities of Gilead Sciences Inc insiders. , Part 5

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gilead Sciences Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Gilead Sciences Inc since 2005. The reporting company's ticker symbol is GILD. The reporting company's CIK number is 882095.
The total value of stock buying since 2005 is $2,912,783.
The total value of stock sales since 2005 is $2,429,890,319.
The total value of stock option exercises since 2005 is $473,010,194.



Table 2. Detailed insider stock purchases, sales, and option exercises of Gilead Sciences Inc insiders (GILD) , Part 5
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-08-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-08-01 Martin John C (Chairman and CEO) Sale 282,242 61.79 17,440,862
2013-08-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-07-30 Madigan John W Sale 249,000 61.97 15,430,779
2013-07-30 Madigan John W Option Ex 249,000 13.89 3,458,859
2013-07-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 57.34 5,160,150
2013-07-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2013-07-02 Cogan John Francis Sale 17,000 51.66 878,288
2013-07-02 Cogan John Francis Option Ex 17,000 10.99 186,881
2013-07-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 52.35 1,570,470
2013-07-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-07-01 Washington Robin L (SVP, CFO) Sale 45,600 52.31 2,385,427
2013-07-01 Washington Robin L (SVP, CFO) Option Ex 45,600 23.79 1,084,596
2013-07-01 Martin John C (Chairman and CEO) Sale 282,242 52.30 14,759,845
2013-07-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-06-07 Cogan John Francis Sale 110,000 52.15 5,736,940
2013-06-07 Cogan John Francis Option Ex 110,000 10.99 1,209,230
2013-06-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 52.96 1,588,860
2013-06-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-06-03 Martin John C (Chairman and CEO) Sale 282,242 53.32 15,049,990
2013-06-03 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-05-10 Lofton Kevin E Option Ex 5,852 .00 0
2013-05-10 Whitley Richard James Option Ex 5,852 .00 0
2013-05-10 Cogan John Francis Option Ex 5,852 .00 0
2013-05-10 Wilson Gayle E Option Ex 5,852 .00 0
2013-05-10 Davignon Etienne Option Ex 5,852 .00 0
2013-05-10 Hills Carla A Option Ex 5,852 .00 0
2013-05-10 Wold Olsen Per Option Ex 5,852 .00 0
2013-05-10 Madigan John W Option Ex 5,852 .00 0
2013-05-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 50.20 1,506,120
2013-05-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-05-01 Martin John C (Chairman and CEO) Sale 282,242 50.17 14,160,927
2013-05-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-04-11 Washington Robin L (SVP, CFO) Sale 968 50.20 48,593
2013-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 48.67 1,460,010
2013-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-04-01 Washington Robin L (SVP, CFO) Sale 13,000 48.23 626,951
2013-04-01 Washington Robin L (SVP, CFO) Option Ex 13,000 25.99 337,844
2013-04-01 Martin John C (Chairman and CEO) Sale 282,242 48.24 13,615,071
2013-04-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-03-27 Washington Robin L (SVP, CFO) Sale 45,000 47.07 2,118,150
2013-03-27 Washington Robin L (SVP, CFO) Option Ex 45,000 27.07 1,218,150
2013-03-14 Washington Robin L (SVP, CFO) Sale 4,304 45.85 197,321
2013-03-05 Washington Robin L (SVP, CFO) Sale 45,000 44.41 1,998,449
2013-03-05 Washington Robin L (SVP, CFO) Option Ex 45,000 24.30 1,093,275
2013-03-04 Washington Robin L (SVP, CFO) Sale 9,800 43.68 428,044
2013-03-04 Washington Robin L (SVP, CFO) Option Ex 9,800 23.68 232,034
2013-03-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 43.25 1,297,470
2013-03-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-03-01 Moore Nicholas G Option Ex 167 .00 0
2013-03-01 Martin John C (Chairman and CEO) Sale 282,242 43.24 12,203,579
2013-03-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-02-28 Wold Olsen Per Buy 10,000 43.05 430,490
2013-01-28 Washington Robin L (SVP, CFO) Sale 11,550 39.48 456,028
2013-01-28 Washington Robin L (SVP, CFO) Option Ex 11,550 19.09 220,431
2013-01-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 115,000 74.67 8,587,625
2013-01-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 113,000 29.98 3,387,175
2013-01-02 Martin John C (Chairman and CEO) Sale 141,121 74.50 10,514,220
2013-01-02 Martin John C (Chairman and CEO) Option Ex 141,121 15.27 2,154,212
2012-12-10 Martin John C (Chairman and CEO) Option Ex 12,794 15.64 200,059
2012-12-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 22,000 75.34 1,657,458
2012-12-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 21,000 29.00 609,105
2012-12-03 Martin John C (Chairman and CEO) Sale 145,500 75.04 10,917,883
2012-12-03 Martin John C (Chairman and CEO) Option Ex 145,500 8.94 1,301,206
2012-12-01 Wilson Gayle E Option Ex 3,131 .00 0
2012-11-30 Moore Nicholas G Sale 65,000 74.96 4,872,530
2012-11-30 Moore Nicholas G Option Ex 65,000 28.68 1,863,875
2012-11-28 Denny James M Sale 20,000 73.91 1,478,220
2012-11-28 Denny James M Option Ex 64,000 24.05 1,539,520
2012-11-19 Young Kevin (EVP, Commercial Operations) Sale 360,000 74.31 26,751,240
2012-11-19 Young Kevin (EVP, Commercial Operations) Option Ex 360,000 29.00 10,441,800
2012-11-16 Young Kevin (EVP, Commercial Operations) Sale 100,746 74.66 7,521,998
2012-11-16 Young Kevin (EVP, Commercial Operations) Option Ex 100,746 17.12 1,724,771
2012-11-12 Washington Robin L (SVP, CFO) Sale 111,900 73.11 8,181,232
2012-11-12 Washington Robin L (SVP, CFO) Option Ex 111,900 50.49 5,649,492
2012-11-07 Washington Robin L (SVP, CFO) Sale 4,099 66.30 271,763
2012-11-07 Washington Robin L (SVP, CFO) Option Ex 2,500 54.14 135,350
2012-11-05 Washington Robin L (SVP, CFO) Option Ex 3,000 .00 0
2012-11-02 Milligan John F (President and COO) Sale 70,000 67.01 4,690,700
2012-11-02 Milligan John F (President and COO) Option Ex 70,000 17.50 1,224,790
2012-11-01 Whitley Richard James Sale 7,226 67.81 490,002
2012-11-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 22,000 68.00 1,496,044
2012-11-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 21,000 29.00 609,105
2012-11-01 Metza Kristen (SVP, Human Resources) Sale 30,000 67.93 2,037,810
2012-11-01 Metza Kristen (SVP, Human Resources) Option Ex 30,000 42.94 1,288,290
2012-11-01 Martin John C (Chairman and CEO) Sale 145,450 67.92 9,878,382
2012-11-01 Martin John C (Chairman and CEO) Option Ex 145,450 8.94 1,300,759
2012-10-31 Washington Robin L (SVP, CFO) Sale 2,925 67.85 198,470
2012-10-31 Washington Robin L (SVP, CFO) Option Ex 2,925 48.66 142,330
2012-10-29 Milligan John F (President and COO) Option Ex 11,180 8.94 99,982
2012-10-26 Davignon Etienne Sale 20,000 67.24 1,344,860
2012-10-24 Washington Robin L (SVP, CFO) Sale 625 68.45 42,781
2012-10-24 Washington Robin L (SVP, CFO) Option Ex 625 47.20 29,500
2012-10-22 Washington Robin L (SVP, CFO) Sale 7,650 66.16 506,131
2012-10-22 Washington Robin L (SVP, CFO) Option Ex 7,650 42.69 326,540
2012-10-03 Milligan John F (President and COO) Sale 70,000 69.85 4,889,220
2012-10-03 Milligan John F (President and COO) Option Ex 70,000 17.50 1,224,790
2012-10-02 Washington Robin L (SVP, CFO) Sale 14,750 68.62 1,012,189
2012-10-02 Washington Robin L (SVP, CFO) Option Ex 14,750 47.35 698,486
2012-10-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 22,000 67.64 1,487,992
2012-10-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 21,000 29.00 609,105
2012-10-01 Martin John C (Chairman and CEO) Sale 145,450 67.78 9,858,746
2012-10-01 Martin John C (Chairman and CEO) Option Ex 145,450 8.94 1,300,759
2012-09-18 Washington Robin L (SVP, CFO) Sale 4,500 67.25 302,625
2012-09-18 Washington Robin L (SVP, CFO) Option Ex 4,500 49.81 224,145
2012-09-17 Washington Robin L (SVP, CFO) Sale 57,250 64.83 3,711,345
2012-09-17 Washington Robin L (SVP, CFO) Option Ex 57,250 49.62 2,840,573
2012-09-13 Metza Kristen (SVP, Human Resources) Sale 90,000 59.95 5,395,500
2012-09-13 Metza Kristen (SVP, Human Resources) Option Ex 75,000 41.92 3,144,225
2012-09-10 Washington Robin L (SVP, CFO) Sale 9,000 59.78 538,020
2012-09-10 Washington Robin L (SVP, CFO) Option Ex 9,000 49.81 448,290
2012-09-04 Alton Gregg H (EVP, Corp & Med Affairs) Sale 22,000 57.50 1,265,066
2012-09-04 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 21,000 29.00 609,105
2012-09-04 Milligan John F (President and COO) Sale 140,000 57.41 8,037,680
2012-09-04 Milligan John F (President and COO) Option Ex 140,000 17.50 2,449,580
2012-09-04 Martin John C (Chairman and CEO) Sale 145,450 57.84 8,413,264
2012-09-04 Martin John C (Chairman and CEO) Option Ex 145,450 8.94 1,300,759
2012-09-01 Metza Kristen (SVP, Human Resources) Option Ex 15,000 47.20 708,000
2012-08-30 Washington Robin L (SVP, CFO) Sale 3,466 57.48 199,239
2012-08-14 Moore Gordon Earle Option Ex 252,000 14.54 3,665,340
2012-08-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 60,000 57.95 3,476,820
2012-08-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 60,000 23.45 1,407,000
2012-08-02 Washington Robin L (SVP, CFO) Sale 29,500 57.73 1,703,035
2012-08-02 Washington Robin L (SVP, CFO) Option Ex 29,500 47.35 1,396,972
2012-08-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 12,000 54.08 648,996
2012-08-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 11,000 21.98 241,835
2012-08-01 Metza Kristen (SVP, Human Resources) Sale 30,000 54.02 1,620,690
2012-08-01 Metza Kristen (SVP, Human Resources) Option Ex 30,000 40.95 1,228,500
2012-08-01 Martin John C (Chairman and CEO) Sale 145,450 54.05 7,860,845
2012-08-01 Martin John C (Chairman and CEO) Option Ex 145,450 8.94 1,300,759
2012-07-27 Alton Gregg H (EVP, Corp & Med Affairs) Sale 70,000 55.03 3,851,890
2012-07-27 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 70,000 20.67 1,447,040
2012-07-27 Washington Robin L (SVP, CFO) Sale 2,888 55.35 159,850
2012-07-27 Washington Robin L (SVP, CFO) Option Ex 2,888 38.17 110,234
2012-07-22 Metza Kristen (SVP, Human Resources) Option Ex 2,000 .00 0
2012-07-21 Metza Kristen (SVP, Human Resources) Option Ex 2,500 .00 0
2012-07-20 Washington Robin L (SVP, CFO) Sale 4,331 53.26 230,682
2012-07-20 Washington Robin L (SVP, CFO) Option Ex 4,331 38.17 165,314
2012-07-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 8,000 52.00 416,000
2012-07-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 8,000 19.36 154,880
2012-07-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 8,000 51.27 410,128
2012-07-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 7,000 19.36 135,520
2012-07-02 Martin John C (Chairman and CEO) Sale 145,450 51.32 7,464,639
2012-07-02 Martin John C (Chairman and CEO) Option Ex 145,450 8.94 1,300,759
2012-06-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 8,000 49.01 392,072
2012-06-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 7,000 19.36 135,520
2012-06-01 Martin John C (Chairman and CEO) Sale 145,450 48.84 7,104,505
2012-06-01 Martin John C (Chairman and CEO) Option Ex 145,450 8.94 1,300,759
2012-05-12 Lofton Kevin E Option Ex 3,632 .00 0
2012-05-12 Whitley Richard James Option Ex 3,632 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of GILD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gilead Sciences Inc (symbol GILD, CIK number 882095) see the Securities and Exchange Commission (SEC) website.